Hemoglobin-Albumin-Lymphocyte-Platelet Index and Risk of In-Hospital Mortality in 793 Adult Patients Hospitalized for Acute Exacerbations of Chronic Obstructive Pulmonary Disease
Open Access
- 19 February 2025
- journal article
- Published by International Scientific Information, Inc. in Medical Science Monitor
- Vol. 31, e947098
Abstract
BACKGROUND Chronic obstructive pulmonary disease (COPD) is a progressive inflammatory condition of the airways, recognized as a leading cause of morbidity and mortality worldwide. Acute exacerbations of COPD (AECOPD) significantly worsen clinical outcomes and often result in hospitalization, which is linked to increased mortality and a substantial socioeconomic burden. This study aimed to evaluate the role of the hemoglobin-albumin-lymphocyte-platelet (HALP) index in predicting the risk of in-hospital mortality in adult patients hospitalized for AECOPD. MATERIAL AND METHODS A total of 793 patients (mean±SD age: 71.5±10.2 years, range 23.8-98.4 years, 69.1% males) hospitalized with AECOPD were included in this retrospective cohort study. Data on patient demographics, comorbidities, laboratory findings on the day of hospital admission, intensive care unit (ICU) stay (on initial admission or over the course of hospitalization), and in-hospital mortality rates were recorded. The factors predicting in-hospital mortality risk were analyzed via multivariate logistic regression analysis. Receiver operating characteristic (ROC) curve analysis was performed to determine the performance of HALP score in identifying patients at risk of in-hospital mortality. RESULTS Multivariate logistic regression analysis revealed a significant association of lower HALP scores (OR 0.758, 95% CI: 0.586 to 0.980, P=0.034) with increased risk of in-hospital mortality. ROC curve analysis revealed the HALP score to identify patients at risk of in-hospital mortality at a cut-off value of <16.84 (area under curve [AUC]: 0.678, 95% CI: 0.615-0.742, P<0.001) with a sensitivity of 69.1%, specificity of 60.4%, and a NPV of 96.3%. CONCLUSIONS Our findings indicate that the HALP score (at a cut-off value of <16.84) can identify AECOPD patients at high risk of in-hospital mortality, emphasizing its potential use as a simple immune-nutritional prognostic biomarker in assisting accurate prognostic assessment and timely adjustment of treatment options in at-risk patients.Keywords
This publication has 40 references indexed in Scilit:
- Trends in Mechanical Ventilation Among Patients Hospitalized With Acute Exacerbations of COPD in the United States, 2001 to 2011Chest, 2015
- Factors affecting mortality following emergency admission for chronic obstructive pulmonary diseaseBMC Pulmonary Medicine, 2014
- Inflammatory Biomarkers and Exacerbations in Chronic Obstructive Pulmonary DiseaseJAMA, 2013
- Predictors of Mortality in Hospitalized Adults with Acute Exacerbation of Chronic Obstructive Pulmonary Disease. A Systematic Review and Meta-analysisAnnals of the American Thoracic Society, 2013
- Comorbidities and Short-term Prognosis in Patients Hospitalized for Acute Exacerbation of COPDChest, 2012
- Routine Laboratory Tests can Predict In-hospital Mortality in Acute Exacerbations of COPDLung, 2011
- Severity assessment tools for predicting mortality in hospitalised patients with community-acquired pneumonia. Systematic review and meta-analysisThorax, 2010
- The Potential Value of Biomarkers in Diagnosis and Staging of COPD and ExacerbationsSeminars in Respiratory and Critical Care Medicine, 2010
- Biomarkers in the management of COPDEuropean Respiratory Review, 2009
- COPD exacerbations: defining their cause and preventionThe Lancet, 2007